Retrospective Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Dec 18, 2023; 13(6): 344-356
Published online Dec 18, 2023. doi: 10.5500/wjt.v13.i6.344
Risk stratification of renal transplant recipients using routine parameters: Implication of learning from SARS-CoV-2 into transplant follow-up program
Abbas Ghazanfar, Madiha Abbas, Md Walid Hussain, Malik Kayal
Abbas Ghazanfar, Renal and Transplant Unit, St Georges University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom
Madiha Abbas, Department of Anesthesia and Intensive Care Medicine, Epsom and St Helier University Hospitals NHS Trust, London KT8 7EG, United Kingdom
Md Walid Hussain, Malik Kayal, Department of Renal and Transplant Surgery, St Georges University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom
Author contributions: Ghazanfar A and Abbas M contributed to study design, data analysis, manuscript writing; Ghazanfar A and Hussain Md W contributed to data collection; Kayal M contributed to manuscript writing support.
Institutional review board statement: Compliance with local ethical and data protection policies. Registered with St Georges University Hospitals NHS Foundation Trust Quality Assurance Department. Registration no AUD1000854.
Informed consent statement: Online assessment confirmed that no patient consent or ethical approval from NHS HRA/REC was required.
Conflict-of-interest statement: Authors have no conflict of interest related to the content of this publication.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at email address a.ghazanfar@nhs.net.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Abbas Ghazanfar, MBBS, FACS, FCPS, FEBS, FICS, FRCS, RCPathME, Chairman, Doctor, Researcher, Senior Lecturer, Surgeon, Renal and Transplant Unit, St Georges University Hospitals NHS Foundation Trust, London SW17 0QT, London SW17 0QT, United Kingdom. a.ghazanfar@nhs.net
Received: July 20, 2023
Peer-review started: July 20, 2023
First decision: September 5, 2023
Revised: October 21, 2023
Accepted: November 13, 2023
Article in press: November 13, 2023
Published online: December 18, 2023
ARTICLE HIGHLIGHTS
Research background

Various studies have been done to separately study routine laboratory markers to stratify patients with high risk of morbidity and mortality but very little is known in renal transplant patients.

Research motivation

This study provides a new way of looking at the significance of routine laboratory tests with an aim to risk stratify renal transplant recipients into high-risk sub-groups.

Research objectives

This study will help in shaping new policies and guidelines by providing individualized shielding advice, self-isolation guidance and booster coronavirus disease 2019 vaccination. Moreover, this will also help to plan better follow-up strategies for transplant patient. Addressing and correcting these parameters during a follow-up program can reduce the risk of morbidity and mortality in renal transplant recipients (RTxR).

Research methods

Retrospective observational study to analyze the data of our renal transplant follow-up program for various routine parameters and their impact of patient outcomes.

Research results

This study has identified some routinely used modifiable parameters in predicting a higher risk of mortality and morbidity.

Research conclusions

This knowledge can be used in RTxR follow-up programs by addressing these parameters early to help reduce the morbidity and mortality in RTxRs.

Research perspectives

This knowledge can be used in RTxR follow-up programs by addressing these parameters early to help reduce the morbidity and mortality in RTxRs.